Back to search

Imatinib in small cell lung cancer

Data up to Jan 2025

Published2003
Citations30
References21

Total Citations Per Year

Abstract

References (21)

Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia

2001 • 5,189 citations

Cancer Statistics, 2003

2003 • 3,302 citations

A gene hypermethylation profile of human cancer.

2001 • 2,043 citations

Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand.

1987 • 1,627 citations

Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study

2002 • 1,195 citations

Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study

2002 • 1,069 citations

Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia

2000 • 897 citations

STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications

2001 • 698 citations

KIT Extracellular and Kinase Domain Mutations in Gastrointestinal Stromal Tumors

2000 • 648 citations

Inhibition of KIT Tyrosine Kinase Activity: A Novel Molecular Approach to the Treatment of KIT-Positive Malignancies

2002 • 582 citations

Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation.

2002 • 396 citations

Autocrine growth of small cell lung cancer mediated by coexpression of c-kit and stem cell factor.

1996 • 275 citations

The selective tyrosine kinase inhibitor STI571 inhibits small cell lung cancer growth.

2000 • 271 citations

Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571

2000 • 238 citations

Update of phase I study of imatinib (STI571) in advanced soft tissue sarcomas and gastrointestinal stromal tumors: a report of the EORTC Soft Tissue and Bone Sarcoma Group

2002 • 231 citations

Phase II study of topotecan in patients with extensive-stage small-cell carcinoma of the lung: an Eastern Cooperative Oncology Group Trial.

1996 • 206 citations

Characterization of c-kit expression in small cell lung cancer: prognostic and therapeutic implications.

2003 • 146 citations

Platelet-derived growth factor receptors: A therapeutic target in solid tumors

2001 • 145 citations

The biology of lung cancer.

1993 • 143 citations

Small Cell Lung Cancer

1997 • 135 citations

Justification for Evaluating New Anticancer Drugs in Selected Untreated Patients With Extensive-Stage Small-Cell Lung Cancer: An Eastern Cooperative Oncology Group Randomized Study

1992 • 42 citations

Cited By (0)

No citing papers found in database

Imatinib in small cell lung cancer (2003) – Lung Cancer | Metascience Observatory Explorer